Consult
Log In
Menu
Consult
Log in
About PierianDx

Next Generation Medicine.

We're making genomics the standard of care in the fight against cancer and hereditary disease.

Schedule Consult

Our History: Pioneers in Precision Medicine

Invigorated by the sequencing of the human genome, breakthroughs in basic science are now delivering blockbuster therapies in cancer and other critical indications. A key player, Washington University in St. Louis, led the Human Genome Project and was among the first to validate and report its experience utilizing next generation sequencing clinically. While a leader at Washington University, PierianDx founder and President Dr. Rakesh Nagarajan was a critical innovator of technology-enabled solutions that allowed for processing and interpreting the near-overwhelming amounts of data created in “omic” analyses. The reputation and critical role of Washington University’s molecular diagnostics lab, as well as Dr. Nagarajan’s ongoing participation in key industry leadership groups such as the College of American Pathologists (CAP), has positioned PierianDx as a key enabler of precision medicine.

1200px-WashU_St._Louis_seal.svg
Human Genome Complete

2003

Washington University in St. Louis plays a crucial role in the mapping of the first human genome.

CGW-Screenshot-Laptop_ALK_300x300
Clinical Genomics Workspace is Born

2011

Washington University creates CAP/CLIA lab for NGS testing. The Genetics and Molecular Pathology departments collaborate to develop Clinical Genomics Workspace (CGW), groundbreaking software for clinical genomics.

brittney-butler-498222-unsplash-258812-edited
PierianDx Established

2014

Washington University performs a technology transfer after 50+ labs visit to learn how to operationalize clinical NGS testing. Key team members form PierianDx. 

handshake-square
Vision Achieves Funding

2015

After two releases of CGW that offer multi-tenant and exome sequencing support, PierianDx closes Series A funding (14.2 million).

PierianDx Pune, India office
India Office Established

2016

PierianDx opens an office in Pune, India to support software development and large-scale biocuration efforts. 

Administrators
Burgeoning Partner Network

2018

PierianDx has 40+ customers supported by nearly 70 medical, scientific, and technical experts.

NovaSeq -- Courtesy of Illumina
Partnership with Industry Leader, Illumina

Early 2019

PierianDx partners with Illumina to deliver optimized interpretation and reporting solutions for Illumina pan-cancer profiling assays.

Global Expansion photo by Kyle Glenn
Global Expansion

Mid 2019

PierianDx experiences rapid expansion into Europe, Middle East, and Asia Pacific regions. 

Clinical Sharing Network
Mature Partner Network

2020

A network of over 100 clinical institutions contributes knowledge via the partner sharing network.

Our Leadership

Mark McDonough

Mark McDonough

Chief Executive Officer

Rakesh Nagarajan, MD, PhD

Rakesh Nagarajan, MD, PhD

Founder, President, and Chief Technical and Visionary Officer

Chris Callahan

Chris Callahan

Chief Operating Officer, Executive Vice President

James L. Starr

James L. Starr

Chief Financial Officer
Debbie Thompson

Debbie Thompson

Chief People Officer

Lindsay Mateo

Lindsay Mateo

Chief Business Officer

Aditya Phatak

Aditya Phatak

General Manager India Office

Andy Dearing

Andy Dearing

Senior Vice President, Operations

Andy Bredemeyer, PhD

Andy Bredemeyer, PhD

Vice President, Product

Mukesh Sharma, PhD

Mukesh Sharma, PhD

Vice President, Product

 

Will Moller, MS

Will Moller, MS

Vice President, Product
Ilaria Fasanella, PhD

Ilaria Fasanella, PhD

Director of International Sales, EMEA and APAC

Sumit Deshmukh

Sumit Deshmukh

Vice President, Product Development
Shan Moledina

Shan Moledina

Regional Vice President of Commercial Development

headshot_s 2-2-1

Nabil Hafez

Regional Vice President of Commercial Development

Garreth-Hippe-PierianDx-600x450-optimized

Garreth Hippe, MBA

Vice President, Business Development
George Buchanan

George Buchanan

Vice President, Commercial Transactions

Pavan Kalantri

Pavan Kalantri

Chief Software Architect

Mike O'Brien

Mike O'Brien

Senior Vice President of Product Development

Dylan Pollard

Dylan Pollard

Director, Customer Sales

Cates Mallaney

Cates Mallaney, PhD

Vice President, Customer Success

Board of Directors

Joseph Boorady

Chairman

Operating Partner with Health Catalyst Capital

https://www.linkedin.com/in/joeboorady/

Bryan Carey

Director

Advisor, Health Catalyst Capital

www.linkedin.com/in/bryan-j-carey-59a7845      

Fred Hessler

Director

Retired Managing Director, Health Care Group, Citigroup

https://www.healthdesign.org/about-us/meet-team/frederick-hessler

Kerry Propper

Director

Co-founder and Managing Director, ATW Partners

https://www.linkedin.com/in/kerrypropper/

Rakesh Nagarajan, MD, PhD

Director

Founder, President, and Chief Technical and Visionary Officer, PierianDx
    

Mark McDonough

Director

Chief Executive Officer

https://www.linkedin.com/in/mark-mcdonough-b1055216/

 

Barnard Buscemi

Director

Retired Investment Officer, Inova Health System

https://www.linkedin.com/in/barnard-buscemi-cfa-86218669/

Other Key Investors

Charles Boorady

Founding Manager

Health Catalyst Capital

https://www.linkedin.com/in/charlesboorady/

Cody Nystrom

Managing Director

SJF Ventures

https://www.linkedin.com/in/codynystrom/

Matthew Jenkins

Head, Corporate Development

RTI International 

https://www.linkedin.com/in/mrjenkins/

Anthony Meyer

Managing Member

Meyer Venture Partners

https://www.linkedin.com/in/anthonyemeyer/

handshake.jpg

Work with Us!

PierianDx is looking for the best and brightest to join our fast-moving, creative and collaborative team. Join the team who is helping our clients fulfill the promise of personalized medicine.

Career Openings

Upcoming Events

We look forward to meeting you soon! Here's where we'll be next.

 HIMSS

Screen Shot 2021-04-20 at 3.53.58 PM

 

 

AMP 2020
November 16-20, 2020
ACMG
March 18-20, 2020
American Society of Clinical Oncology | Chicago, IL
May 31, 2019 - June 4, 2019
AMP
November 19-21,2020

What Some of Our Customers Say

About PierianDx

"I knew that with the resources we had, there was no way to create something that would rival a system like the CGW. As we've set up reflex testing in various cancer types, we have been well supported to scale the massive undertaking..."

- Nikoletta Sidiropoulos, MD - Medical Director, University of Vermont Medical Center

University-of-Vermont_white

 

“There's going to be a bottleneck in the professional component as well sometimes. PierianDx allowed us to widen that bottleneck and to have more uniformity of reporting.”

- Eric Loo, MD - Asst. Professor, Pathology and Lab Medicine, Dartmouth-Hitchcock

Dartmouth_white

“We chose PierianDx because their technology combined with expert scientific and clinical services will help accelerate TriCore’s ability to expand our NGS test offerings and provide enhanced clinically actionable information.

- Eric Carbonneau - Director Core Laboratory Operations, TriCore Reference Laboratories

Tricore_white

“A new partnership with PierianDx expands our reporting to include current clinical trials and up-to- the-minute treatment options, all linked to NorthShore’s Electronic Medical Record.”

- NorthShore University HealthSystem Kellogg Cancer Center 2017 Annual Report

Northshore_white